FIELD: medicine.
SUBSTANCE: invention represents a differential diagnostic technique for chronic viral hepatitis and fatty liver disease in the patients suffering dyslipidemia syndrome, consisting in the fact that patient's blood serum is measured for an enzyme strength of superoxide dismutase (SOD) antioxidant system, which is assessed by spectrophotometric method, and if SOD is 23 units/mg of protein or less, fatty liver disease is diagnosed; if the SOD concentration is more than 23 units/mg of protein, chronic viral hepatitis is diagnosed.
EFFECT: reducing injuries, higher accessibility and simplicity with high sensitivity, specificity and efficiency.
4 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF CHRONIC VIRAL HEPATITIS AND FATTY LIVER DISEASE IN PATIENTS WITH DYSLIPIDEMIA SYNDROME | 2014 |
|
RU2552299C1 |
| METHOD OF FATTY LIVER DISEASE DIAGNOSTICS IN PATIENTS SUFFERING FROM CHRONIC VIRAL HEPATITIS C | 2006 |
|
RU2347226C2 |
| METHOD FOR PREDICTING FIBROUS HEPATIC PROCESS AT CHRONIC VIRAL HEPATITIS | 2004 |
|
RU2270451C1 |
| METHOD OF DIAGNOSING LIVER AFFECTION IN CASE OF ATHEROGENIC DYSLIPIDEMIA | 2008 |
|
RU2403567C2 |
| METHOD FOR VERIFYING CHRONIC HEPATIC PATHOLOGY IN PATIENTS WITH ARTERIAL HYPERTENSION | 2013 |
|
RU2547246C1 |
| METHOD OF DIAGNOSIS OF LIVER AND BILIFEROUS TRACT DISEASES ACCOMPANIED BY CYTOLIS | 0 |
|
SU1119659A1 |
| METHOD OF DIAGNOSIS OF CHRONIC DISEASES OF LIVER | 0 |
|
SU1142105A1 |
| METHOD OF SCREENING STUDY OF RISK OF DEVELOPING LIVER DAMAGE OF DIFFERENT ORIGINS | 2017 |
|
RU2675015C1 |
| METHOD FOR PREDICTING CIRRHOSIS AT CHRONIC VIRAL HEPATITIS | 2003 |
|
RU2244306C1 |
| METHOD FOR PREDICTING NON-ALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2021 |
|
RU2765848C1 |
